Pulse Biosciences (NASDAQ:PLSE) Shares Down 9.6%

Pulse Biosciences, Inc. (NASDAQ:PLSE)’s stock price fell 9.6% during mid-day trading on Tuesday . The company traded as low as $16.85 and last traded at $16.85. 91,226 shares traded hands during trading, a decline of 58% from the average session volume of 215,827 shares. The stock had previously closed at $18.64.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Pulse Biosciences to a “sell” rating in a report on Tuesday, August 6th.

Pulse Biosciences Stock Performance

The firm has a market cap of $1.07 billion, a PE ratio of -21.58 and a beta of 1.75. The stock has a fifty day moving average price of $16.54 and a 200-day moving average price of $11.94.

Institutional Trading of Pulse Biosciences

Institutional investors have recently modified their holdings of the company. Rhumbline Advisers boosted its holdings in Pulse Biosciences by 6.7% in the 2nd quarter. Rhumbline Advisers now owns 25,729 shares of the company’s stock worth $288,000 after acquiring an additional 1,608 shares during the period. BNP Paribas Financial Markets boosted its holdings in Pulse Biosciences by 63.6% in the 1st quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock worth $66,000 after acquiring an additional 2,952 shares during the period. Quest Partners LLC purchased a new position in Pulse Biosciences in the 2nd quarter worth approximately $91,000. Bank of New York Mellon Corp boosted its holdings in Pulse Biosciences by 23.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 50,914 shares of the company’s stock worth $570,000 after acquiring an additional 9,639 shares during the period. Finally, Price T Rowe Associates Inc. MD purchased a new position in Pulse Biosciences in the 1st quarter worth approximately $88,000. Hedge funds and other institutional investors own 76.95% of the company’s stock.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.